|Bid||0.0000 x 1100|
|Ask||0.0000 x 800|
|Day's Range||4.6200 - 4.9800|
|52 Week Range||3.9300 - 47.2800|
|Beta (5Y Monthly)||1.51|
|PE Ratio (TTM)||22.45|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Canadian marijuana company Aphria (NASDAQ: APHA) is often viewed as a (relatively) safe pot stock pick. Aphria's peers, including Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC), have recently gone on acquisition and expansion sprees, scaring some investors away with rapid growth strategy implementation. Aphria has noted their examples, and is instead taking an asset-light approach to business and focusing on its core operations in Canada.
These companies are terrible places for millennial investors to be putting their hard-earned money to work.
NEW YORK, NY / ACCESSWIRE / October 21, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below.